← Open Payments lookup

JULIE OMISHAKIN: Open Payments

NPI 1962748954 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$476 in 19 payments from 12 companies in 2025. Trend: 2023 $831 · 2024 $701 · 2025 $476

Food & beverage: $476
CompanyPaymentsAmount
Gilead Sciences, Inc.7$204
Janssen Pharmaceuticals, Inc2$56
ABBVIE INC.1$28
GlaxoSmithKline, LLC.1$27
ViiV Healthcare Company1$26
Neurocrine BioSciences, Inc.1$25
Novo Nordisk Inc1$24
Merck Sharp & Dohme LLC1$21
Exact Sciences Corporation1$19
AstraZeneca Pharmaceuticals LP1$16

Products named: Descovy, INVEGA SUSTENNA, MAVYRET, AREXVY, APRETUDE, INGREZZA, Rybelsus, GARDASIL 9.

Industry payments across CA — which companies pay providers there.